March 2011 FDA Recall Drug by Luitpold Pharmaceuticals, Inc.
D-1378-2012 - Presence of Particulate Matter

This Class II drug recall was voluntarily initiated by Luitpold Pharmaceuticals, Inc. on March 15, 2011 for the product Drug. The FDA reported the reason for recall as presence of particulate matter. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1378-2012

Reason for Recall
Presence of Particulate Matter: In the course of inspecting retention samples visual particles were observed.
Initiated
03-15-2011
Reported
06-20-2012
Quantity
30 mL: 2,078,800 vials; 100 mL: 167,100 vials

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Luitpold Pharmaceuticals, Inc.
Nationwide, Puerto Rico, and Abu Dhabi
CONCENTRATED SODIUM CHLORIDE INJECTION, USP, 23.4% a) 30 mL SINGLE DOSE VIAL, (NDC 0517-2930-25), b) 100 mL PHARMACY BULK PACKAGE (NDC 0517-2900-25), Rx Only, AMERICAN REGENT, INC. SHIRLEY, NY 11967.

Batch or Lot Expiration Information

Lot# 30 mL Lots: 9198, 9252, 9299, 9305, 9402, 9423, 9432, 9553, 9595, 9646, 9681, 9737, 9797, 9831, 0051, 0095, 0362; 100 mL Lots: 9225, 9492, 9711, 0007, 0058